S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
NASDAQ:ACCD

Accolade (ACCD) Stock Forecast, Price & News

$6.11
+0.05 (+0.83%)
(As of 05/20/2022 12:00 AM ET)
Add
Compare
Today's Range
$5.71
$6.29
50-Day Range
$5.28
$18.90
52-Week Range
$4.61
$55.47
Volume
1.33 million shs
Average Volume
3.66 million shs
Market Capitalization
$411.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
3.01
30 days | 90 days | 365 days | Advanced Chart
Receive ACCD News and Ratings via Email

Sign-up to receive the latest news and ratings for Accolade and its competitors with MarketBeat's FREE daily newsletter.

Accolade logo

About Accolade

Accolade, Inc. develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was founded in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Current Symbol
NASDAQ:ACCD
Fax
N/A
Employees
2,350
Year Founded
N/A

Sales & Book Value

Annual Sales
$310.02 million
Book Value
$12.78 per share

Profitability

Net Income
$-123.12 million
Pretax Margin
-41.53%

Debt

Price-To-Earnings

Miscellaneous

Free Float
60,229,000
Market Cap
$411.14 million
Optionable
Not Optionable

Company Calendar

Last Earnings
4/28/2022
Today
5/21/2022
Next Earnings (Estimated)
7/14/2022
Fiscal Year End
2/28/2023

MarketRank

Overall MarketRank

2.43 out of 5 stars

Business Services Sector

89th out of 462 stocks

Business Services, Not Elsewhere Classified Industry

40th out of 141 stocks

Analyst Opinion: 4.3Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 1.3 5 -4 -3 -2 -1 -













Accolade (NASDAQ:ACCD) Frequently Asked Questions

Is Accolade a buy right now?

14 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Accolade in the last twelve months. There are currently 7 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Accolade stock.
View analyst ratings for Accolade
or view top-rated stocks.

When is Accolade's next earnings date?

Accolade is scheduled to release its next quarterly earnings announcement on Thursday, July 14th 2022.
View our earnings forecast for Accolade
.

How were Accolade's earnings last quarter?

Accolade, Inc. (NASDAQ:ACCD) posted its quarterly earnings results on Thursday, April, 28th. The company reported ($0.51) earnings per share for the quarter, missing the consensus estimate of ($0.45) by $0.06. The company earned $93.76 million during the quarter, compared to the consensus estimate of $91.58 million. Accolade had a negative trailing twelve-month return on equity of 22.57% and a negative net margin of 39.72%. The company's revenue for the quarter was up 58.3% on a year-over-year basis. During the same quarter in the previous year, the business posted ($0.13) earnings per share.
View Accolade's earnings history
.

What guidance has Accolade issued on next quarter's earnings?

Accolade issued an update on its FY 2023 earnings guidance on Monday, May, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $350.00 million-$365.00 million, compared to the consensus revenue estimate of $387.39 million.

What price target have analysts set for ACCD?

14 Wall Street analysts have issued twelve-month target prices for Accolade's shares. Their forecasts range from $6.00 to $61.00. On average, they expect Accolade's share price to reach $22.29 in the next year. This suggests a possible upside of 264.7% from the stock's current price.
View analysts' price targets for Accolade
or view top-rated stocks among Wall Street analysts.

Who are Accolade's key executives?
Accolade's management team includes the following people:
  • Mr. Rajeev Singh, Chairman & CEO (Age 53, Pay $828k)
  • Mr. Robert Cavanaugh, Pres (Age 53, Pay $706.12k)
  • Mr. Stephen H. Barnes CPA, CFO & Treasurer (Age 50, Pay $610.6k)
  • Mr. Phong Nguyen, Chief Operating Officer
  • Mr. Harish Naidu, Chief Technology Officer
  • Mr. Todd Friedman, Sr. VP of Investor Relations
  • Mr. Richard Eskew, Exec. VP, Gen. Counsel, Chief Privacy Officer & Sec.
  • Mr. William S. Morrison, Sr. VP of Strategy & Corp. Devel.
  • Ms. Carolina Lobo, Chief Marketing Officer
  • Ms. Donna Snow, Sr. VP of Clinical Solutions
What is Rajeev Singh's approval rating as Accolade's CEO?

152 employees have rated Accolade CEO Rajeev Singh on Glassdoor.com. Rajeev Singh has an approval rating of 74% among Accolade's employees.

What other stocks do shareholders of Accolade own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Accolade investors own include (HON), CVS Health (CVS), Johnson & Johnson (JNJ), Raytheon Technologies (RTX), Alibaba Group (BABA), Home Depot (HD), Procter & Gamble (PG), Thermo Fisher Scientific (TMO), Cisco Systems (CSCO) and Intel (INTC).

When did Accolade IPO?

(ACCD) raised $176 million in an initial public offering on Thursday, July 2nd 2020. The company issued 8,800,000 shares at $19.00-$21.00 per share. Goldman Sachs, Morgan Stanley and BofA Securities served as the underwriters for the IPO and Piper Sandler, Credit Suisse, William Blair, Baird and SVB Leerink were co-managers.

What is Accolade's stock symbol?

Accolade trades on the NASDAQ under the ticker symbol "ACCD."

Who are Accolade's major shareholders?

Accolade's stock is owned by a variety of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (7.44%), ARK Investment Management LLC (7.24%), Brown Advisory Inc. (6.10%), BlackRock Inc. (5.54%), JPMorgan Chase & Co. (5.34%) and Bellevue Group AG (5.02%).
View institutional ownership trends for Accolade
.

Which institutional investors are selling Accolade stock?

ACCD stock was sold by a variety of institutional investors in the last quarter, including Select Equity Group L.P., Wellington Management Group LLP, Goldman Sachs Group Inc., ARK Investment Management LLC, Renaissance Technologies LLC, AlphaCrest Capital Management LLC, Vanguard Group Inc., and Sumitomo Mitsui Trust Holdings Inc..
View insider buying and selling activity for Accolade
or view top insider-selling stocks.

Which institutional investors are buying Accolade stock?

ACCD stock was purchased by a variety of institutional investors in the last quarter, including Brown Advisory Inc., JPMorgan Chase & Co., Bellevue Group AG, Rock Springs Capital Management LP, BlackRock Inc., State Street Corp, Essex Investment Management Co. LLC, and Capital Fund Management S.A..
View insider buying and selling activity for Accolade
or or view top insider-buying stocks.

How do I buy shares of Accolade?

Shares of ACCD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Accolade's stock price today?

One share of ACCD stock can currently be purchased for approximately $6.11.

How much money does Accolade make?

Accolade has a market capitalization of $411.14 million and generates $310.02 million in revenue each year. The company earns $-123.12 million in net income (profit) each year or ($2.01) on an earnings per share basis.

How many employees does Accolade have?

Accolade employs 2,350 workers across the globe.

What is Accolade's official website?

The official website for Accolade is accolade.com.

How can I contact Accolade?

Accolade's mailing address is 660 W. GERMANTOWN PIKE SUITE 500, PLYMOUTH MEETING PA, 19462. The company can be reached via phone at 206-926-8100 or via email at [email protected].

This page was last updated on 5/21/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.